BMO Capital analyst Keith Bachman raised the firm’s price target on Check Point (CHKP) to $240 from $215 and keeps an Outperform rating on the shares. The company reported billings growth of 20% y/y, or about 15% y/y adjusting for pulled-in/early deals, which is its highest billings growth rate in over a decade, the analyst tells investors in a research note. BMO is more encouraged that Check Point’s go-to-market changes and broadening portfolio can drive improved FY26 growth, the firm added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHKP:
- Check Point price target raised to $215 from $210 at UBS
- Balanced Outlook on Check Point Software: Strong Billings Growth Amid Caution on Revenue and Valuation
- Check Point price target raised to $235 from $220 at Barclays
- Check Point Software Reports Strong Q3 2025 Results
- Check Point Software Reports Strong Growth Amid Challenges